Understanding the pharmaceutical aspects of dendrimers for the delivery of anticancer drugs.
Dendrimers are emerging class of nanoparticles used in targeted drug delivery system. These are radially symmetric molecules with well-defined, homogeneous, and monodisperse structure. Due to the nano size, they can easily cross the biological membrane and increase bioavailability. Also, the surface functionalization facilitates the targeting to the particular site of action, assist the high drug loading and improves therapeutic efficiency of drug. These properties make dendrimers advantageous over conventional drug delivery system. This article explains the features of dendrimers along with their method of synthesis such as divergent growth method, convergent growth method, double exponential and mixed method, hyper-core and branched method. Dendrimers are effectively used in anticancer delivery and can be targeted at the site of tumor either by active or passive targeting. There are three mechanisms by which drugs interact with dendrimers, and they are physical encapsulation, electrostatic interaction, chemical conjugation of drug molecules. Drug releases from dendrimer either by in vivo cleavage of the covalent bond between drug-dendrimer complexes or by physical changes or stimulus like pH, temperature, etc.